R. Morris

P. Dagum, G. Berry, U. Christians, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The novel immunosuppressant SDZ‐RAD protects rat brain slices from cyclosporine‐induced reduction of high‐energy phosphates

U. Christians, D. Leibfritz, L. Benet, 2000, British journal of pharmacology.

Up‐regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post‐transplant obliterative airway disease

J. Polak, R. Morris, A. Bishop, 2000, The Journal of pathology.

Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts.

O. Hess, T. Carrel, B. Walpoth, 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line.

A. Gazdar, J. Whitsett, M. O’Reilly, 1988, Biochimica et biophysica acta.

Regulation of the macrophage vacuolar ATPase and phagosome-lysosome fusion by Histoplasma capsulatum.

G. E. Dean, R. Morris, G. Ciraolo, 1999, Journal of immunology.

Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.

R. Morris, C. Gregory, M. Billingham, 1995, Transplantation proceedings.

ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.

U. Christians, R. Morris, T. van Gelder, 2001, Transplantation proceedings.

immunosuppressant SDZ-RAD Successful treatment of acute, ongoing rat lung allograft rejection with the novel

G. Berry, U. Christians, R. Morris, 2013 .

Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.

G. Berry, U. Christians, R. Morris, 2000, The Annals of thoracic surgery.

Internalization of pseudomonas exotoxin a utilizes the α macroglobulin receptor/low density lipoprotein receptor related protein

R. Morris, C. Saelinger, 1995 .

Level of receptor-associated protein moderates cellular susceptibility to pseudomonas exotoxin A

D. Strickland, R. Morris, C. Saelinger, 1995, Infection and immunity.

Reduced temperature alters Pseudomonas exotoxin A entry into the mouse LM cell

R. Morris, C. Saelinger, 1986, Infection and immunity.

Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts

P. Bonventre, R. Morris, S. Leppla, 1984, Infection and immunity.

Diphtheria toxin does not enter resistant cells by receptor-mediated endocytosis

R. Morris, C. Saelinger, 1983, Infection and immunity.

Inhibition of the activity of pseudomonas toxin by methylamine.

R. Morris, C. Saelinger, D. FitzGerald, 1983, Reviews of infectious diseases.

Essential role of calcium in cellular internalization of Pseudomonas toxin

R. Morris, C. Saelinger, D. FitzGerald, 1982, Infection and immunity.

Receptor-mediated internalization of pseudomonas toxin by mouse fibroblasts

R. Morris, C. Saelinger, D. FitzGerald, 1980, Cell.

Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection.

R. Morris, X. Huang, T. Brazelton, 1997, Transplantation proceedings.

Pharmacologic Immunosuppressants in Xenotransplantation

R. Morris, T. Brazelton, A. Cheung, 1997 .

Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.

G. Berry, U. Christians, R. Morris, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.

R. Morris, B. Hausen, Randall E. Morris, 1997, Clinics in chest medicine.

Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum1

R. Morris, S. Newman, L. Gootee, 2006, The Journal of Immunology.

Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts.

G. Berry, R. Morris, X. Huang, 2000, Transplantation.

The role of respiratory epithelium in a rat model of obliterative airway disease.

G. Berry, R. Morris, T. Brazelton, 2000, Transplantation.

Chronic rejection: The result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosupressive therapies

R. Morris, T. Brazelton, B. Adams, 1999, Inflammation Research.

Alterations in inducible nitric oxide synthase (iNOS) and nitrotyrosine (NitroY) during re-epithelialization of heterotopic rat tracheal composite grafts.

G. Berry, J. Polak, R. Morris, 1999, Transplantation proceedings.

Small airway obliteration in a new swine heterotopic lung and bronchial allograft model.

R. Morris, E. Taskinen, T. Ikonen, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.

G. Berry, H. Reichenspurner, M. Nitschke, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation.

R. Morris, T. Brazelton, B. Adams, 1997, Transplantation Proceedings.

Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.

G. Berry, H. Reichenspurner, M. Nitschke, 1997, Transplantation.

Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model.

G. Rosen, G. Berry, R. Morris, 1997, Transplantation.

Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.

R. Morris, X. Huang, R. Braun-Dullaeus, 1997, Transplantation Proceedings.

Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.

G. Berry, R. Morris, C. Gregory, 1995, Transplantation proceedings.

EPITHELIAL RE-GROWTH IS ASSOCIATED WITH INHIBITION OF OBLITERATIVE AIRWAY DISEASE IN ORTHOTOPIC TRACHEAL ALLOGRAFTS IN NON-IMMUNOSUPPRESSED RATS1

G. Berry, R. Morris, T. Ikonen, 2000, Transplantation.

How Does Leflunomide Modulate the Immune Response in Rheumatoid Arthritis?

G. Wahl, C. Frangou, M. Herrmann, 1999, BioDrugs.

15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.

R. Morris, D. Yuh, 1991, Transplantation Proceedings.

Altered surfactant function and structure in SP-A gene targeted mice.

B. Stripp, A. Jobe, J. Whitsett, 1996, Proceedings of the National Academy of Sciences of the United States of America.

The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies

J. Gummert, R. Rubin, R. Morris, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts.

G. Berry, R. Morris, M. Stalder, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immortalization of subpopulations of respiratory epithelial cells from transgenic mice bearing SV40 large T antigen.

J. Whitsett, J. Cuppoletti, J. C. Clark, 1994, The American journal of physiology.

Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis.

S. Sherwood, W. Throndset, R. Morris, 1998, Transplantation proceedings.

Airway Goblet Cells and Respiratory Epithelial Injury in an Animal Model of Obliterative Airways Disease (OAD)

R. Morris, T. Ikonen, A. Dosanjh, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells.

J. Whitsett, R. Morris, G. Ciraolo, 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Identification of Heat Shock Protein 60 as the Ligand on Histoplasma capsulatum That Mediates Binding to CD18 Receptors on Human Macrophages1

R. Morris, F. Gomez, S. Newman, 2003, The Journal of Immunology.

This information is current as Human Macrophages Mediates Binding to CD 18 Receptors on That Histoplasma capsulatum Ligand on Identification of Heat Shock Protein 60 as the

R. Morris, F. Gomez, S. Newman, 2002 .

Ultrastructural visualization of virus-induced surface antigens. Comparative studies of three immunohistochemical techniques.

R. Morris, R. Fritz, 1975, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

COMPARATIVE STUDIES OF THREE IMMUNOHISTOCHEMICAL TECHNIQUES

R. Morris, R. Fritz, 1975 .

Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.

R. Morris, J. Wang, M. Billingham, 1994, Transplantation proceedings.

New Agents on the Horizon

R. Morris, J. Klupp, 2001 .

Graft-versus-host disease prevention by rapamycin: cellular mechanisms.

R. Morris, N. Chao, B. J. Chen, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Uptake and processing of toxins by mammalian cells.

R. Morris, C. Saelinger, 1994, Methods in enzymology.

Immunosuppression by the JAK3 Inhibitor CP-690,550 Delays Rejection and Significantly Prolongs Kidney Allograft Survival in Nonhuman Primates

B. Reitz, R. Morris, Sally Zhang, 2005, Transplantation.

Pharmacodynamics in the Development of New Immunosuppressive Drugs

R. Morris, F. Raulf, C. Burkhart, 2004, Therapeutic drug monitoring.

A life-supporting technique of renal allotransplantation in Macaca fascicularis to evaluate novel immunosuppressive drugs in nonhuman primates.

R. Morris, M. Stalder, T. Bîrsan, 2002, The Journal of surgical research.

Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.

U. Christians, R. Morris, J. Klupp, 2001, Transplantation.

Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.

E. Nakakura, G. Blank, R. Morris, 1993, Transplantation.

Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.

P. Huie, V. Dzau, R. Morris, 1993, Transplantation proceedings.

Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.

A. Allison, R. Morris, J. Wang, 1991, Transplantation proceedings.

Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.

A. Allison, R. Morris, R. E. Morris, 1990, Transplantation proceedings.

Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720

R. Morris, G. Wieczorek, C. Pally, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Mycophenolate Mofetil: A Report of the Consensus Panel

L. Shaw, D. Holt, R. Morris, 1995, Therapeutic drug monitoring.

Cellular enzyme-linked immunospecific assay (CELISA). I. A new micromethod that detects antibodies to cell-surface antigens.

P. T. Thomas, R. Morris, R. Hong, 1982, Human immunology.

Pharmacodynamics of immunosuppressive drugs.

R. Morris, C. Dambrin, J. Klupp, 2000, Current opinion in immunology.

SIROLIMUS (RAPAMYCIN) HALTS AND REVERSES PROGRESSION OF ALLOGRAFT VASCULAR DISEASE IN NON-HUMAN PRIMATES1

G. Berry, U. Christians, P. Yock, 2000, Transplantation.

Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non‐human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening

U. Christians, P. Yock, J. Gummert, 2000 .

Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening

U. Christians, P. Yock, J. Gummert, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.

G. Berry, U. Christians, L. Benet, 1999, Transplantation.

Prevention of Arterial Restenosis by Rapamycin and Mycophenolate Mofetil: A New Role for Novel Immunosuppressants in the Prevention of Post-Balloon Angioplasty Restenosis?

R. Morris, C. Gregory, X. Huang, 1997 .

Rapamycin: A New and Highly Active Immunosuppressive Macrolide with an Efficacy Superior to Cyclosporine

R. Morris, J. Wang, B. Meiser, 1989 .

Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT

U. Christians, R. Morris, W. Jacobsen, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.

R. Morris, M. Stalder, T. Bîrsan, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

New small molecule immunosuppressants for transplantation: review of essential concepts.

R. Morris, R. E. Morris, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immunopharmacology of new xenobiotic immunosuppressive molecules.

R. Morris, R. E. Morris, 1992, Seminars in nephrology.

Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.

R. Morris, J. Wang, Morris Re, 1991, Transplantation proceedings.

Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.

R. Morris, J. Wang, R. E. Morris, 1991, Transplantation proceedings.

Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin‐independent inhibitor of NFAT

U. Christians, R. Morris, W. Jacobsen, 2004 .

Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.

J. Gummert, S. Sherwood, R. Morris, 1999, The Journal of pharmacology and experimental therapeutics.

Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection.

R. Morris, T. Ikonen, A. Dosanjh, 2002, Pulmonary pharmacology & therapeutics.

Mechanisms of Action of New Immunosuppressive Drugs

R. Morris, 1995, Kidney international. Supplement.

A novel inhibitor of nuclear factor-kappa B and activator protein-1 transcription factors in T cells suppresses host-versus-graft alloreactivity in vivo.

R. Morris, M. Suto, M. Morikawa, 1997, Transplantation proceedings.

EFFECTS OF HUMANIZED MONOCLONAL ANTIBODY TO RHESUS CD11a IN RHESUS MONKEY CARDIAC ALLOGRAFT RECIPIENTS12

L. Presta, R. Poston, R. Morris, 2000 .

Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy.

E. Nakakura, R. Morris, P. Jardieu, 1996, Transplantation.

Human Dendritic Cell Activity against Histoplasma capsulatum Is Mediated via Phagolysosomal Fusion

R. Morris, G. Ciraolo, S. Newman, 2005, Infection and Immunity.

Lectin activity of the major surfactant protein (SP-A) may participate in, but is not required for, binding to rat type II cells.

J. Whitsett, G. Ross, R. Morris, 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Validation of the biotinyl ligand-avidin-gold technique.

R. Morris, G. Ciraolo, C. Saelinger, 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys1

R. Morris, M. Stalder, T. Bîrsan, 2003, Transplantation.

Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.

G. Berry, R. Morris, M. Masek, 1991, Transplantation proceedings.

Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.

I. Figari, M. Palladino, R. Morris, 1991, Transplantation proceedings.

A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.

R. Morris, J. Wu, R. Shorthouse, 1990, Transplantation proceedings.

Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.

G. Berry, U. Christians, L. Benet, 2000, Transplantation.

Enhancement of antigenic site detection with gold labeled secondary and tertiary antibodies using the immunogold-silver staining method.

R. Morris, R. Cardell, B. Giffin, 1993, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

Respiratory epithelial expression of integrin αvβ6 in chronic progressive allograft rejection

R. Morris, T. Ikonen, A. Dosanjh, 2004 .

Hamster cardiac xenografts are protected against antibody mediated damage, early after transplantation to Lewis rats

P. Vriens, R. Morris, R. Robbins, 2001, Xenotransplantation.

Trafficking ofPseudomonas exotoxin a in mammalian cells

R. Morris, C. Saelinger, G. Foertsch, 1985, European Journal of Clinical Microbiology.

Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.

P. Biberfeld, O. Korsgren, R. Morris, 1997, Transplantation proceedings.

Mouse liver contains a Pseudomonas aeruginosa exotoxin A-binding protein

M. Thompson, R. Morris, C. Saelinger, 1991, Infection and immunity.

Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy

R. Morris, M. Stalder, T. Bîrsan, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

An Examination of the Structure and Functions of the Bovine Vacuolar ATPase Using Antisense Oligonucleotides

G. E. Dean, R. Morris, J. E. Strasser, 1993 .

Optimal visualization of immunogold-silver staining of hepatic PEPCK with epipolarized light microscopy.

R. Morris, R. Cardell, K. Gao, 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Visualization of intracellular trafficking of proteins.

R. Morris, C. Saelinger, 1990, Methods in enzymology.

Visualization of intracellular trafficking: use of biotinylated ligands in conjunction with avidin-gold colloids.

R. Morris, C. Saelinger, 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Visualization of Intracellular Trafficking

R. Morris, C. Saelinger, 1984 .

Tumor and histocompatibility antigen interaction: direct visualization by a double-label bridging technique for immuno-electron microscopy.

R. Morris, C. David, C. David, 1982, Molecular immunology.

Combined use of immunoferritin and immunocolloidal gold for the simultaneous demonstration of two antigens by immuno-electron microscopy.

R. Morris, C. Saelinger, Randal E. Morris, 1982, Stain technology.

Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection.

R. Morris, G. Wieczorek, J. van Oostrum, 2005, Journal of proteome research.

Receptor-mediated entry of Pseudomonas toxin: methylamine blocks clustering step

R. Morris, C. Saelinger, M. Manhart, 1983, Infection and immunity.

The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF‐transgenic porcine hearts

V. Starnes, R. Morris, D. Cramer, 2007, Xenotransplantation.

Tacrolimus for prevention of liver allograft rejection: clinical trials and tribulations

B. Brown, R. Morris, 1995, The Lancet.

Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.

R. Poston, R. Morris, R. Robbins, 1999, Circulation.

VIRAL SERINE PROTEINASE INHIBITOR (SERP-1) EFFECTIVELY DECREASES THE INCIDENCE OF GRAFT VASCULOPATHY IN HETEROTOPIC HEART ALLOGRAFTS1

G. Berry, R. Morris, B. Hausen, 2001 .

VIRAL SERINE PROTEINASE INHIBITOR (SERP‐1) EFFECTIVELY DECREASES THE INCIDENCE OF GRAFT VASCULOPATHY IN HETEROTOPIC HEART ALLOGRAFTS.: Abstract# 895 Poster Board #‐Session: P152‐III

G. Berry, R. Morris, B. Hausen, 2000, Transplantation.

Expression of virion and tumor-specific antigens on the surface of chick embryo cells infected with strain MC29 avian leukosis virus.

R. Morris, R. Fritz, 1976, Cancer research.

Compared with Cyclosporine, ISATX247 Significantly Prolongs Renal-Allograft Survival in a Nonhuman Primate Model

S. Griffey, R. Morris, C. Gregory, 2004, Transplantation.

Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.

P. Huie, R. Morris, J. Wang, 1993, Transplantation proceedings.

Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.

J. Gummert, R. Morris, T. van Gelder, 2002, Transplant immunology.

Brief treatment with rapamycin in vivo increases responsiveness to alloantigens measured by the mixed lymphocyte response.

R. Morris, P. Mohacsi, 1992, Immunology letters.

The antiproliferative effect of leflunomide on vascular smooth muscle cells in vitro is mediated by selective inhibition of pyrimidine biosynthesis.

R. Morris, R. V. Nair, W. Cao, 1996, Transplantation proceedings.

Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.

R. Morris, R. V. Nair, W. Cao, 1995, Immunology letters.

Efficacy of Rapamycin and FK 506 in Prolonging Rat Hind Limb Allograft Survival

R. Morris, K. Bickel, B. Press, 1994, Annals of surgery.

Immunosuppression in renal transplantation: some aspects for the modern era.

S. Chadban, K. Budde, W. Arns, 2008, Transplantation reviews.

A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2.

P. Kao, R. Morris, R. E. Morris, 1996, Transplantation proceedings.

Newer immunosuppressive drugs: a review.

J. Gummert, R. Morris, T. Ikonen, 1999, Journal of the American Society of Nephrology : JASN.

Evaluation of the clinical and histologic features of renal allograft rejection in cats.

S. Griffey, R. Morris, R. Ramsamooj, 2002, Veterinary surgery : VS.

An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs.

S. Griffey, R. Morris, C. Gregory, 2002, Veterinary surgery : VS.

Zymolyase Treatment Exposes p55 Antigen of Pneumocystis carinii

R. Morris, P. Walzer, A. Smulian, 1998, The Journal of eukaryotic microbiology.

Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices.

R. Morris, G. Ciraolo, S. Newman, 1997, Journal of immunology.

Digestion of Histoplasma capsulatum yeasts by human macrophages.

R. Morris, W. Bullock, S. Newman, 1992, Journal of immunology.

Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.

R. Morris, C. Gregory, B. Sturges, 1998, Transplantation proceedings.

Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.

R. Morris, T. Brazelton, 1996, Current opinion in immunology.

Ketoconazole potentiates cyclosporine immunosuppression and toxicity in mice.

T. Blaschke, R. Morris, J. Anderson, 1987, Transplantation proceedings.

Enhanced Killing of Candida albicans by Human Macrophages Adherent to Type 1 Collagen Matrices via Induction of Phagolysosomal Fusion

R. Morris, B. Bhugra, S. Newman, 2005, Infection and Immunity.

In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.

B. Reitz, R. Morris, Sally Zhang, 2004, Journal of immunological methods.

Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs

S. Griffey, R. Morris, C. Gregory, 2003, Transplantation.

Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides

R. Morris, 1992 .

Modified Noble Plication for the Prevention of Intestinal Intussusception After Renal Transplantation in Dogs

S. Griffey, R. Morris, C. Gregory, 2003, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Failure to demonstrate a role for line Ib tumor-associated surface antigen in the etiology of age-dependent polioencephalomyelitis.

R. Morris, D. M. Bentley, J. Stinnett, 1982, Molecular immunology.

Brequinar sodium (Dup 785) is a highly potent antimetabolite immunosuppressant that suppresses heart allograft rejection

R. Morris, M. Murphy, 1991 .

Cellular enzyme-linked immunospecific assay (CELISA). IV. Inhibition of endogenous cellular alkaline phosphatase activity.

R. Morris, D. Horowitz, 1984, Journal of immunological methods.

A comparison of the in vitro and in vivo immunologic activities of concanavalin A and its succinylated derivative.

R. Morris, P. DeValeria, G. Hoyt, 1987, Transplantation proceedings.

Inhibition of cellular protein synthesis by vaccinia virus surface tubules.

R. Morris, H. Bubel, G. Mbuy, 1982, Virology.

Immunosuppressants: cellular and molecular mechanisms of action.

M. Suthanthiran, T. Strom, R. Morris, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

AnkB, a Periplasmic Ankyrin-Like Protein inPseudomonas aeruginosa, Is Required for Optimal Catalase B (KatB) Activity and Resistance to Hydrogen Peroxide

D. Hassett, M. Klotz, K. Blumenthal, 2000, Journal of bacteriology.

Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.

R. Morris, H. Silva, R. Shorthouse, 1996, Transplantation proceedings.

Localization of ClC-2 Cl- channels in rabbit gastric mucosa.

J. Cuppoletti, R. Morris, G. Ciraolo, 2001, American journal of physiology. Cell physiology.

Shigella Infection of Henle Intestinal Epithelial Cells: Role of the Host Cell

P. Bonventre, R. Morris, T. L. Hale, 1979, Infection and immunity.

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

A. Levinson, I. Figari, M. Palladino, 1990, The Journal of experimental medicine.

Comparison of the Effects of Tacrolimus and Cyclosporine on the Pharmacokinetics of Mycophenolic Acid

U. Christians, M. Barten, R. Morris, 2001, Therapeutic drug monitoring.

High-performance liquid chromatographic assay with a simple extraction procedure for sensitive quantification of mycophenolic acid in rat and human plasma.

U. Christians, J. Gummert, R. Morris, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Pharmacodynamics of Mycophenolate Mofetil after Heart Transplantation: New Mechanisms of Action and Correlations with Histologic Severity of Graft Rejection

J. Gummert, M. Barten, R. Morris, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells

M. Kastan, J. Milner, C. Canman, 1997, Oncogene.

The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement

M. Stegall, A. Gaber, K. Romero, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.

M. Stegall, S. Chadban, P. Nickerson, 2017, Transplantation.

Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

M. Stegall, R. Morris, R. Mannon, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Leflunomide analog, MNA-715, plus cyclosporine reduces renal allograft rejection in mismatched dogs.

S. Griffey, R. Morris, C. Gregory, 2001, Transplantation proceedings.

The Transforming Growth Factor‐Betas: A New Family of Immunoregulatory Molecules

A. Levinson, M. Palladino, H. Starnes, 1990, Annals of the New York Academy of Sciences.

Strongly reduced alloreactivity and long‐term survival times of cardiac allografts in Vav1‐ and Vav1/Vav2‐knockout mice

B. Nuesslein-Hildesheim, R. Morris, G. Wieczorek, 2007, Transplant international : official journal of the European Society for Organ Transplantation.

Therapeutic monitoring of mycophenolic acid: A consensus panel report

L. Shaw, V. Armstrong, P. Halloran, 1998 .

Leflunomide and malononitrilamides.

R. Morris, H. T. Silva Júnior, Hello Tedesco Silva, 1997, The American journal of the medical sciences.

Leflunomide and malononitriloamides.

R. Morris, H. Silva, Randall Ellis Morris, 1997, Expert opinion on investigational drugs.

Chicken antilymphocyte globulin: a source of heterologous enhancing antibody.

R. Morris, N. Shumway, Randall B. Griepp, 1977, Transplantation proceedings.

Azurophilic granules of human neutrophils contain CD14

D. Rodeberg, G. Babcock, R. Morris, 1997, Infection and immunity.

Hyperacute rejection of orthotopic cardiac allografts in dogs following solubilized antigen pretreatment.

R. Morris, E. Dong, P. Caves, 1973, Transplantation.

PHARMACODYNAMICS OF MYCOPHENOLIC ACID IN HEART ALLOGRAFT RECIPIENTS: CORRELATION OF LYMPHOCYTE PROLIFERATION AND ACTIVATION WITH PHARMACOKINETICS AND GRAFT HISTOLOGY1

J. Gummert, M. Barten, R. Morris, 2000, Transplantation.

Immunosuppression in cardiac transplantation: a new era in immunopharmacology

R. Morris, R. V. Nair, 1995, Current opinion in cardiology.

Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.

P. Huie, R. Morris, C. Gregory, 1993, Transplantation.

Quantification of Immunosuppression by Flow Cytometry in Stable Renal Transplant Recipients

R. Morris, M. Stalder, B. Holm, 2003, Therapeutic drug monitoring.

Treatment by Mycophenolate Mofetil of Advanced Graft Vascular Disease in Non‐Human Primate Recipients of Orthotopic Aortic Allografts

G. Berry, P. Fitzgerald, R. Morris, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

T cell subsets required for protection against age-dependent polioencephalomyelitis of C58 mice.

R. Morris, D. M. Bentley, 1982, Journal of immunology.

S. Watson, R. Morris, D. M. Bentley, 1983, Infection and immunity.

Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.

S. Griffey, R. Morris, C. Gregory, 1996, Transplantation proceedings.

Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation.

R. Morris, J. Wu, R. Shorthouse, 1990, Transplantation Proceedings.

Association of down-regulation of cytokine activity with rat hind limb allograft survival.

P. Huie, R. Morris, R. Sibley, 1995, Transplantation.

The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro

R. Morris, R. Yatscoff, C. Dambrin, 2004, Transplant international : official journal of the European Society for Organ Transplantation.

Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.

R. Morris, R. E. Morris, J. Wu, 1991, Transplantation proceedings.

Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat.

S. Griffey, R. Morris, S. Hou, 1997, Transplantation.

Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report

M. Sarwal, P. Nickerson, D. Axelrod, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Gold enhancement of gold-labeled probes: gold-intensified staining technique (GIST).

R. Morris, G. Ciraolo, C. Saelinger, 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Sotrastaurin (AEB071) Alone and in Combination With Cyclosporine A Prolongs Survival Times of Non-Human Primate Recipients of Life-Supporting Kidney Allografts

A. Blancher, R. Morris, G. Wieczorek, 2012, Transplantation.

Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD.

U. Christians, L. Benet, N. Serkova, 2001, Transplantation proceedings.

Donor treatment with the lazeroid U74389G reduces ischemia-reperfusion injury in a rat lung transplant model.

R. Morris, R. Ramsamooj, B. Hausen, 1997, The Annals of thoracic surgery.

New World monkeys as a primate model for xenografts in the absence of anti-Gal.

R. Morris, U. Galili, C. Gregory, 1996, Transplantation proceedings.

The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF‐transgenic pig‐to‐primate life‐supporting kidney xenografts

U. Christians, J. Higgins, R. Morris, 2005, Xenotransplantation.

Drug Evaluation Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis Leflunomide and malononitriloamides

R. Morris, H. Tedesco, 1997 .

Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.

S. Griffey, R. Morris, C. Gregory, 1996, Transplantation.

Leflunomide prolongs pulmonary allograft and xenograft survival.

B. Reitz, R. Morris, R. Robbins, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy

J. Chan, R. Morris, M. Billingham, 2004, Xenotransplantation.

In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis.

R. Morris, M. Löffler, H. Silva, 1997, Transplantation proceedings.

Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.

P. Kao, R. Morris, A. Chao, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.

G. Berry, U. Christians, J. Gummert, 1999, Transplantation.

Leflunomide (HWA 486) and its analog suppress T- and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after balloon catheter injury.

R. Morris, X. Huang, B. Zheng, 1995, Transplantation proceedings.

Hyperacute rejection of hDAF‐transgenic pig organ xenografts in cynomolgus monkeys: influence of pre‐existing anti‐pig antibodies and prevention by the αGAL glycoconjugate GAS914

G. Berry, B. Reitz, R. Morris, 2004, Xenotransplantation.

Anti‐pig antibody levels in non‐human primates of various origin

R. Morris, H. Schuurman, T. Lam, 2004, Xenotransplantation.

In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non‐human primates

R. Morris, M. Stalder, W. Fitzsimmons, 2003 .

In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates

R. Morris, M. Stalder, W. Fitzsimmons, 2003, Transplant international : official journal of the European Society for Organ Transplantation.

Use of echocardiography to assess function of hDAF-transgenic pig cardiac xenografts.

R. Morris, M. Stalder, D. Borie, 2005, Transplantation proceedings.

Susceptibility of Mammalian Cells to Pseudomonas Exotoxin A

R. Morris, C. Saelinger, 1993 .

Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation

C. Poets, R. Morris, B. Hausen, 1998, Transplant international : official journal of the European Society for Organ Transplantation.

Weight gain after lung transplantation.

R. Morris, J. Theodore, R. Doyle, 2003, The Journal of Heart and Lung Transplantation.

A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.

E. Nakakura, G. Blank, R. Morris, 1993, Transplantation proceedings.

EFFECTS OF RAPAMYCIN ON GROWTH FACTOR‐STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET‐DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506

R. Morris, P. Mohacsi, R. Pratt, 1995, Transplantation.

PROLONGED INHIBITION OF OBLITERATIVE AIRWAY DISEASE IN MURINE TRACHEAL ALLOGRAFTS BY BRIEF TREATMENT WITH ANTI-LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 (CD11a) MONOCLONAL ANTIBODY1

G. Berry, R. Morris, M. Morikawa, 2001, Transplantation.

A simple reliable method for producing electron dense markers of uniform size for use in immunoelectron microscopy.

R. Morris, C. Saelinger, 1982, Journal of immunological methods.

Mechanism of action for leflunomide in rheumatoid arthritis.

G. Wahl, C. Frangou, V. Strand, 1999, Clinical immunology.

Squirrel monkeys hyperacutely reject porcine musculocutaneous flaps despite a lack of naturally occurring xenoantibodies.

S. Griffey, R. Morris, U. Galili, 1998, Transplantation Proceedings.

Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.

G. Berry, U. Christians, L. Benet, 2000, The Journal of pharmacology and experimental therapeutics.

Contribution of anti-Gal to primate and human IgG binding to porcine endothelial cells.

R. Morris, U. Galili, C. Gregory, 1995, Transplantation.

Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.

U. Christians, N. Guterman, L. Benet, 1998, Journal of chromatography. B, Biomedical sciences and applications.

THE IMMUNOPHARMACOLOGY OF IMMUNOSUPPRESSION BY 15‐DEOXYSPERGUALIN

R. Morris, David Daiho Yuh, 1993, Transplantation.

Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.

M. Miller, R. Morris, H. Iwamoto, 1999, American journal of respiratory cell and molecular biology.

Quilty effect in heterotopic cardiac allografts in malononitrilamide-treated rats.

R. Morris, M. Billingham, S. Slauson, 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Sustained food vacuole formation by axenic Paramecium tetraurelia and the inhibition of membrane recycling by Alcian Blue.

R. Morris, E. Kaneshiro, S. Reuter, 1992, The Journal of protozoology.

Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat.

J. Gummert, R. Morris, M. Barten, 1999, Immunopharmacology and immunotoxicology.

Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats.

R. Morris, H. Silva, R. Shorthouse, 1996, Transplantation proceedings.

Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients.

R. Morris, V. Gudas, P. Carmichael, 1989, Transplantation proceedings.

Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts.

R. Morris, E. Squiers, E. Cozzi, 2002, Transplantation proceedings.

Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin

M. Mann, H. E. von der Leyen, V. Dzau, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Religious obstacles and warrants for the donation of body parts.

B. Meiser, R. Morris, G. Hoyt, 1988 .

Immunopharmacology of FK-506.

R. Morris, R. E. Morris, M. Murphy, 1989, Transplantation proceedings.

Efficacy of didemnin B in suppressing allograft rejection in mice and rats.

R. Morris, D. Yuh, R. Zurcher, 1989, Transplantation proceedings.

Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay

S. Sherwood, R. Morris, S. Slauson, 1999 .

Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and

G. Berry, U. Christians, J. Gummert, 2000, Transplantation.

Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure.

U. Christians, R. Morris, T. van Gelder, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Vascular and cellular mechanisms of chronic renal allograft dysfunction.

R. Morris, 2001, Transplantation.

Beware: shifting paradigms ahead

R. Morris, 1996, The Lancet.

Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance.

F. Lazeyras, H. Altermatt, B. Walpoth, 1992, Transplant international : official journal of the European Society for Organ Transplantation.

RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis.

J. Kovarik, J. Loyd, A. Stecenko, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immunogold-silver staining and epipolarized light microscopic detection of phosphoenolpyruvate carboxykinase and glycogen phosphorylase in rat liver

R. Morris, R. Cardell, B. Giffin, 1993, Histochemistry.

Epipolarization microscopic immunogold assay: a combination of immunogold silver staining, enzyme-linked-immunosorbent assay and epipolarization microscopy.

R. Morris, C. Wei, K. Gao, 1995, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.

D. W. Anderson, R. Morris, M. Suto, 1996, Transplantation proceedings.

New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus.

R. Morris, T. van Gelder, C. Dambrin, 2001, Transplantation proceedings.

Graft thrombosis in hDA-transgenic pig hearts transplanted into rhesus monkeys.

G. Berry, R. Morris, M. Masek, 2003, Xenotransplantation.

Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers.

R. Morris, M. Stalder, W. Fitzsimmons, 2003, Transplant immunology.

Assessment of new immunosuppressive drugs in a rat cardiac allograft heterotopic model.

H. Altermatt, B. Walpoth, R. Morris, 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

Mechanism of action for leflunomide in rheumatoid arthritis.

G. Wahl, C. Frangou, V. Strand, 1999, Clinical immunology.

Bronchial epithelial cell-derived cytokine IL-10 and lung fibroblast proliferation.

R. Morris, R. E. Morris, A. Dosanjh, 2001, Transplantation proceedings.

Xenogeneic antibodies are not necessary for chronic rejection of vascularised xenografts

R. Morris, T. Brazelton, N. Briffa, 1999 .

Therapeutic monitoring of mycophenolic acid (MPA): Assays of immune function in peripheral blood predict efficacy for inhibition of histologic graft rejection

J. Gummert, R. Morris, M. Barten, 1999 .

Development of models of graft vascular disease in nonhuman primates: evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange.

P. Fitzgerald, P. Yock, J. Gummert, 1999, Transplantation proceedings.

A new large-animal model for research of graft vascular disease.

P. Fitzgerald, P. Yock, J. Gummert, 1998, Transplantation proceedings.

Prevention and Treatment of Allograft Rejection in Vivo by Rapamycin: Molecular and Cellular Mechanisms of Action

R. Morris, 1993, Annals of the New York Academy of Sciences.

Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1

A. Levinson, I. Figari, M. Palladino, 1990, The Journal of experimental medicine.

Tissue Distribution and Clinical Monitoring of the Novel Macrolide Immunosuppressant SDZ-RAD and Its Metabolites in Monkey Lung Transplant Recipients : Interaction with Cyclosporine 1

G. Berry, U. Christians, L. Benet, 2000 .

The immunologic diagnosis of orthotopic cardiac allograft rejection in dogs.

R. Morris, N. Shumway, E. Dong, 1973, Transplantation proceedings.

microscopy. Optimal visualization of immunogold-silver staining of hepatic PEPCK with epipolarized light

R. Morris, R. Cardell, B. Giffin, 2011 .

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.

B. Wolff, M. Dawid, O. Grenet, 2008, The Journal of clinical investigation.

Prolongation of rat cardiac allograft survival by splenectomy following transplantation.

L. Vistnes, R. Morris, S. Souther, 1974, Transplantation.

Lobular and cellular distribution and content of glycogen synthase in periportal and pericentral hepatocytes of the rat liver

R. Morris, R. Drake, R. Cardell, 1993 .

Enhanced nitric oxide production induced by the administration of L-arginine does not inhibit arterial neointimal formation after overwhelming alloimmune injury.

J. Cooke, R. Morris, C. Gregory, 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.

R. Morris, T. van Gelder, M. Billingham, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.